Molecular Partners AG Sponsored ADR MOLN

4.22 (0.08) (1.86%) as of 25 Sep
Market cap
$160.5M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
112.32 169.75 208.18 261.08 145.31 185.29 98.02 100.98 143.94 176.69
Receivables
2.21 2.63 2.18 1.07 28.06 3.03 2.13 52.67 1.18 0.83
Other current assets
2.40 2.87 4.03 4.81 6.24 1.65 2.86 2.80 0.32 0.48
Total current assets
116.93 175.25 214.38 266.95 179.64 189.65 103.01 156.45 145.43 178.00
Property, Plant, Equpment (Net)
6.31 4.77 6.33 7.58 8.91 10.01 4.37 1.48 1.91 2.45
Goodwill and Intangible Assets (Total)
0.00 0.06 0.24 0.28 0.36 0.37 0.80 0.39 0.03 0.05
Total non-current assets
6.31 4.82 6.56 7.87 9.27 10.38 — — — —
Total Assets
123.24 180.07 220.94 274.82 188.92 200.04 108.18 158.32 0.00 180.49
Accounts Payable
2.13 2.11 1.48 2.25 8.08 6.21 2.08 2.15 0.73 1.01
Accrued Expenses
9.72 8.76 8.41 7.86 10.91 8.23 — — — —
Current Part of Debt
— — — — — — 1.31 — — —
Current Part of Capital Lease
1.46 1.38 1.35 1.26 1.30 1.26 — — — —
Other current liabilities
— — 4.83 6.72 30.98 45.81 26.10 35.47 13.70 14.45
Total current liabilities
13.31 12.25 16.06 18.08 51.28 61.51 29.49 37.62 14.43 15.46
Long Term Debt (Total)
— — — — — — 1.32 — — —
Non-current Revenue (Deferred)
— — — — — — 10.33 21.30 9.73 26.29
Pension and Post-Retirement Liabilities
9.83 5.54 5.64 2.67 7.37 14.59 — — — —
Non-current Liabilities (Other)
0.19 — — 3.81 7.58 3.13 11.23 5.83 4.10 5.61
Total non-current liabilities
12.97 6.94 8.36 10.31 20.26 24.16 — — — —
Total liabilities
26.28 19.19 24.42 28.39 71.53 85.68 52.37 64.75 28.26 47.36
Additional Paid In Capital
469.74 437.18 407.16 377.58 388.42 319.42 — — — —
Common Stock (Net)
4.87 4.58 4.05 3.78 3.53 3.11 2.23 2.17 2.15 2.03
Retained Earnings
(376.29) (279.76) (213.60) (133.90) (274.56) (208.17) (134.92) (91.69) (61.96) (36.53)
Treasury Stock
1.36 1.11 1.09 1.03 — — — — — —
Common Equity (Total)
96.96 160.89 196.52 246.43 117.38 114.36 55.81 93.58 119.11 133.13
Shareholders Equity (Total)
96.96 160.89 196.52 246.43 117.38 114.36 55.81 93.58 119.11 133.13
Shareholders Equity and Liabilities (Total)
123.24 180.07 220.94 274.82 188.92 200.04 — — — —
Shares (Common)
40.38 40.36 36.35 36.05 32.29 32.16 — — — —
Shareholders Equity (Tangible)
96.96 160.83 196.29 246.15 117.02 113.99 — — — —
Net Debt
(112.32) (169.75) (208.18) (261.08) (145.31) (185.29) (95.40) (100.98) (143.94) (176.69)
Total Debt
— — — 5.27 6.64 8.20 2.62 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates